iShares Genomics Immunology and Healthcare ETFIDNA
IDNA
0
Funds holding %
of 7,419 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
18% more capital invested
Capital invested by funds: $41.3M [Q3] → $48.8M (+$7.49M) [Q4]
12% more funds holding
Funds holding: 52 [Q3] → 58 (+6) [Q4]
9.74% more ownership
Funds ownership: 29.47% [Q3] → 39.21% (+9.74%) [Q4]
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
Research analyst outlook
We haven’t received any recent analyst ratings for IDNA.
Financial journalist opinion
Negative
Seeking Alpha
11 hours ago
IDNA: The Cutting Edge Of Medical Science Is A Risky Investment
The iShares Genomics Immunology and Healthcare ETF is invested in 49 companies involved in genomics, immunology and bioengineering. Compared with the biotechnology benchmark IBB, IDNA has value characteristics, but has greatly underperformed, losing over 20% since its inception. Among genomics-focused ETFs, PBE offers a relatively safer choice with better performance and lower volatility.
Neutral
Seeking Alpha
1 month ago
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Positive
ETF Trends
4 months ago
Disruptive Theme of the Week – Breakthroughs in Medicine
Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical breakthroughs and developments and explore a few ways to get actionable exposure to them with ETFs.
Positive
Seeking Alpha
1 year ago
IDNA: Healthcare Dashboard For February
This article provides a monthly dashboard with aggregate industry metrics in the healthcare sector. Fast facts on IDNA, a thematic and volatile biotech ETF. We conclude with 10 healthcare stocks cheaper than their peers in February.
Positive
ETF Trends
1 year ago
Disruptive Tech Theme of the Week: 7 Disruptive Themes for 2024
To use a holiday analogy, I have been checking lists and checking them twice to figure out which of next year's top disruptive investment themes are likely to be nice.
Neutral
ETF Trends
1 year ago
VettaFi Voices On: Accessing Disruptive Innovation
Good Morning, VettaFi Voices! Disruptive innovation is a popular topic, and it encompasses everything from bitcoin and cryptocurrency to electric vehicles to artificial intelligence.
Charts implemented using Lightweight Charts™